Outlook Therapeutics, Inc. (OTLK) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2015: -$54.22M2016: -$5.17M2017: -$33.65M2018: -$25.54M2019: -$16.13M2020: $2.83M2021: $4.61M2022: $8.74M2023: -$14.44M2024: -$73.08M2025: -$32.19M-$32.19M
2015Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$32.19M+56.0%
2024-$73.08M-406.1%
2023-$14.44M-265.3%
2022$8.74M+89.6%
2021$4.61M+63.0%
2020$2.83M+117.5%
2019-$16.13M+36.9%
2018-$25.54M+24.1%
2017-$33.65M-550.5%
2016-$5.17M+90.5%
2015-$54.22M